CRISPR-based microfluidic platform detects respiratory viruses and SARS-CoV-2 variants

Researchers in the US have developed a novel multiplexed diagnostic platform based on CRISPR-based approaches and microfluidics - enabling robust and simultaneous surveillance of multiple viruses and viral variants. Currently, the paper is available on the medRxiv* preprint server pending peer review.

Related Keywords

,Yurchanka Siarhei Shutterstock ,Broad Institute ,Drug Administration ,Image Credit ,Yurchanka Siarhei ,Crispr ,Espiratory ,Cars ,Ars Cov 2 ,Essay ,Cas13 ,Clinical Testing ,Coronavirus ,Iagnostic ,Iagnostics ,Na ,Luorescence ,Microfluidics ,Pandemic ,Respiratory Virus ,Evere Acute Respiratory ,Evere Acute Respiratory Syndrome ,Yndrome ,Ranscription ,Virus ,